AngioDynamics (ANGO) Financials: History & Chart

AngioDynamics, Inc.(ANGO)

Medical - Instruments & Supplies · Latham, NY

$14.76-0.78 (-5.02%)

Delayed quote: Oct 6, 2026, 11:00 AM EDT

About AngioDynamics, Inc.

AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.

Latham, NY

632 employees

www.angiodynamics.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: James C. Clemmer

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended May 2026	Quarter ended Feb 2026	Quarter ended Nov 2025	Quarter ended Aug 2025	Quarter ended May 2025	Quarter ended Feb 2025	Quarter ended Nov 2024	Quarter ended Aug 2024
Revenue	320.17M	86.61M	78.42M	79.43M	75.71M	80.16M	72.00M	72.84M	67.49M
Cost of Goods Sold	145.28M	37.19M	36.94M	37.29M	33.85M	37.94M	33.15M	32.94M	30.77M
Gross Profit	174.89M	49.42M	41.48M	42.14M	41.86M	42.22M	38.86M	39.91M	36.72M
Gross Profit Margin	54.6%	57.1%	52.9%	53.1%	55.3%	52.7%	54.0%	54.8%	54.4%
Total Operating Expenses	214.82M	69.77M	47.91M	44.63M	52.51M	48.01M	48.83M	51.00M	49.82M
Research & Development	29.45M	8.18M	7.08M	7.77M	6.42M	6.59M	6.91M	6.43M	6.29M
Selling, General & Administrative	157.09M	41.39M	38.16M	36.86M	40.69M	36.67M	35.99M	35.98M	36.58M
Operating Income (EBIT)	-39.93M	-20.35M	-6.43M	-2.49M	-10.66M	-5.79M	-9.97M	-11.09M	-13.10M
Operating Margin	-12.5%	-23.5%	-8.2%	-3.1%	-14.1%	-7.2%	-13.9%	-15.2%	-19.4%
Income Before Tax (EBT)	-36.30M	-11.04M	-8.07M	-6.36M	-10.84M	-6.11M	-4.41M	-10.85M	-12.66M
Interest Income	N/A	N/A	N/A	N/A	N/A	3K	135K	234K	606K
Interest Expense	299K	105K	88K	102K	4K	N/A	N/A	N/A	N/A
Other Income/Expense	3.63M	9.32M	-1.64M	-3.87M	-182K	-322K	5.57M	246K	433K
Net Income	-36.74M	-11.40M	-8.08M	-6.35M	-10.90M	-6.05M	-4.41M	-10.74M	-12.80M
Income Tax Expense	442K	370K	12K	-5K	65K	-60K	-2K	-110K	133K
Net Profit Margin	-11.5%	-13.2%	-10.3%	-8.0%	-14.4%	-7.5%	-6.1%	-14.7%	-19.0%
EBITDA	-16.90M	-14.76M	-838K	3.33M	-4.64M	45K	-3.65M	-4.23M	-6.31M
EBITDA Margin	-5.3%	-17.0%	-1.1%	4.2%	-6.1%	0.1%	-5.1%	-5.8%	-9.4%
Depreciation & Amortization	23.02M	5.60M	5.59M	5.82M	6.02M	5.83M	6.32M	6.86M	6.79M
EPS Basic	-0.88	-0.28	-0.19	-0.15	-0.26	-0.15	-0.11	-0.26	-0.31
EPS Diluted	-0.88	-0.28	-0.19	-0.15	-0.26	-0.15	-0.11	-0.26	-0.31
Weighted Average Basic Shares	41.53M	41.53M	41.60M	41.40M	41.17M	40.98M	40.85M	40.92M	40.65M
Weighted Average Diluted Shares	41.53M	41.53M	41.60M	41.40M	41.17M	40.98M	40.85M	40.92M	40.65M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	05/31/2026	05/31/2025	05/31/2024	05/31/2023	05/31/2022	05/31/2021	05/31/2020	05/31/2019
Revenue	320.17M	292.50M	303.91M	338.75M	316.22M	291.01M	264.16M	359.48M
Cost of Goods Sold	145.28M	134.79M	149.22M	164.51M	150.49M	134.22M	113.89M	114.63M
Gross Profit	174.89M	157.71M	154.70M	174.25M	165.73M	156.79M	150.27M	156.00M
Gross Profit Margin	54.6%	53.9%	50.9%	51.4%	52.4%	53.9%	56.9%	43.4%
Total Operating Expenses	214.82M	197.66M	347.13M	225.43M	194.20M	192.07M	317.37M	165.40M
Research & Development	29.45M	26.22M	31.51M	29.88M	30.74M	36.39M	29.68M	29.43M
Selling, General & Administrative	157.09M	145.23M	143.98M	144.25M	133.75M	117.22M	116.51M	116.13M
Operating Income (EBIT)	-39.93M	-39.95M	-192.44M	-51.18M	-28.47M	-35.28M	-167.10M	-9.40M
Operating Margin	-12.5%	-13.7%	-63.3%	-15.1%	-9.0%	-12.1%	-63.3%	-2.6%
Income Before Tax (EBT)	-36.30M	-34.03M	-191.64M	-54.44M	-29.95M	-36.05M	-168.13M	-14.70M
Interest Income	N/A	978K	1.61M	N/A	N/A	N/A	N/A	N/A
Interest Expense	299K	N/A	N/A	2.70M	688K	861K	907K	5.10M
Other Income/Expense	3.63M	5.92M	797K	-3.26M	-1.48M	-769K	-1.04M	-5.31M
Net Income	-36.74M	-33.99M	-184.35M	-52.44M	-26.55M	-31.55M	-166.79M	61.34M
Income Tax Expense	442K	-39K	-7.29M	-2.00M	-3.40M	-4.50M	-1.35M	-3.56M
Net Profit Margin	-11.5%	-11.6%	-60.7%	-15.5%	-8.4%	-10.8%	-63.1%	17.1%
EBITDA	-17.27M	-14.15M	-164.72M	-20.31M	878K	-9.37M	-143.29M	16.48M
EBITDA Margin	-5.4%	-4.8%	-54.2%	-6.0%	0.3%	-3.2%	-54.2%	4.6%
Depreciation & Amortization	22.66M	25.80M	27.71M	30.87M	29.35M	25.92M	23.80M	25.88M
EPS Basic	-0.88	-0.83	-4.59	-1.33	-0.68	-0.82	-4.37	1.64
EPS Diluted	-0.88	-0.83	-4.59	-1.33	-0.68	-0.82	-4.37	1.64
Weighted Average Basic Shares	41.53M	40.98M	40.18M	39.48M	39.01M	38.34M	37.96M	37.48M
Weighted Average Diluted Shares	41.53M	40.98M	40.18M	39.48M	39.01M	38.34M	37.96M	37.48M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.